
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year |
Award Type![]() |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
2016 | R44 | CA199194 | PAR-13-327 | KARSTEN, STANISLAV | NEUROINDX INC. | Automated Platform for Fixed Tissue Microdissection | Complete |
2016 | R44 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | Next-Generation Antibody Discovery and Development Technology | Complete |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
2001 | R44 | CA081952 | PAR-99-101 | CHEE, MARK S. | ILLUMINA, INC. | RANDOM ARRAYS FOR GENE EXPRESSION PROFILING | Complete |
2004 | R44 | CA081903 | PAR-01-106 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS | Complete |
1999 | R43 | CA081958 | PAR-98-066 | HAGEN, FREDERICK S | ICOGENEX CORPORATION | AFFINITY AND TRANSCRIPTASE TECHNOLOGIES | Complete |
2003 | R43 | CA102986 | PAR-01-105 | KRIZMAN, DAVID BURKE | EXPRESSION PATHOLOGY, INC | PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE | Complete |
2009 | R43 | CA138336 | RFA-CA-08-011 | RUIZ, JOSEPH C | TRANSPOSAGEN BIOPHARMACEUTICALS, INC. | TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO | Complete |
2000 | R43 | CA084804 | PAR-99-101 | GOLOVLEV, VAL V | SCI-TEC, INC. | MAGNETIC DISK ARRAY DNA ANALYZER | Complete |
2002 | R43 | CA096079 | PAR-01-105 | HANCOCK, LAWRENCE F | NOMADICS, INC. | POLYMER AMPLIFIED NUCLEIC ACID DETECTION | Complete |
1999 | R43 | CA081962 | PAR-98-066 | GERDES, JOHN CHARLES | XTRANA, INC. | QUANTITATION AND ARCHIVING OF GENE EXPRESSION | Complete |
2007 | R43 | CA125605 | RFA-CA-07-010 | BOGEN, STEVEN A | MEDICAL DISCOVERY PARTNERS, LLC | ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD | Complete |
2003 | R43 | CA103085 | PAR-01-105 | SCHNEIDER, LUKE V | TARGET DISCOVERY | IDBEST DIFFERENTIAL DISPLAY ON PROTEIN CHIPS | Complete |
2000 | R43 | CA086178 | PAR-99-101 | WILLETT, CATHERINE E | PHYLONIX PHARMACEUTICALS, INC. | PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS | Complete |
2002 | R43 | CA096083 | PAR-01-105 | YANG, CHIHAE | LEADSCOPE, INC. | A NOVEL CHEMICAL GENOMICS METHODOLOGY | Complete |
1999 | R43 | CA081965 | PAR-98-066 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
2007 | R43 | CA126668 | RFA-CA-07-008 | GORDON, NEAL FRANCIS | EPITOME BIOSYSTEMS, INC | A STANDARDIZED ANTIBODY MICROARRAY-BASED SYSTEM FOR THE QUANTITATIVE MEASUREMENT | Complete |
2003 | R43 | CA103086 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | ITP-BASED SELECTIVE ENRICHMENT OF LOW ABUNDANCE PROTEINS | Complete |
2000 | R43 | CA086180 | PAR-99-101 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | NOVEL METHOD FOR DETECTING NON-HODGKIN'S LYMPHOMA | Complete |
2002 | R43 | CA097447 | PAR-01-105 | TRNOVSKY, JAN | ONE CELL SYSTEMS, INC | METHOD FOR DETECTING CHRONIC MYELOGENOUS LEUKEMIA CELLS | Complete |
1999 | R43 | CA083382 | PAR-98-066 | MONFORTE, JOSEPH A | GENETRACE SYSTEMS, INC. | EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS | Complete |
2007 | R43 | CA126726 | RFA-CA-07-008 | MEDGHALCHI, SUSAN | FASGEN, INC. | FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER | Complete |
2014 | R43 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY | Complete |
2000 | R43 | CA086181 | PAR-99-101 | SERBEDZIJA, GEORGE N | PHYLONIX PHARMACEUTICALS, INC. | WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING | Complete |
2002 | R43 | CA097482 | PAR-01-105 | LATHAM, GARY J | AMBION, INC. | ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA | Complete |
1999 | R43 | CA083384 | PAR-98-066 | RICHTERICH, PETER | CODONCODE CORPORATION | SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION | Complete |
2007 | R43 | CA128752 | RFA-CA-07-010 | KRAVITZ, RACHEL HANNAH | NEOCLONE BIOTECHNOLOGY INTERNATIONAL | A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS | Complete |
2014 | R43 | CA188154 | PAR-13-327 | FELLMANN, CHRISTOF | MIRIMUS, INC. | RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO | Complete |
2020 | R43 | CA250885 | PAR-18-303 | REDER, NICHOLAS | LIGHTSPEED MICROSCOPY, INC. | Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies | Active |
2000 | R43 | CA086413 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING | Complete |
2002 | R43 | CA097483 | PAR-01-105 | HANNA, MICHELLE M | RIBOMED BIOTECHNOLOGIES, INC. | RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER | Complete |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
1999 | R43 | CA083385 | PAR-98-066 | GOLDRICK, MARIANNA M | AMBION, INC. | DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA | Complete |
2000 | R43 | CA086755 | PAR-99-101 | WOOD, KATHERINE A | TREVIGEN, INC. | HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY | Complete |
2002 | R43 | CA097505 | PAR-01-105 | JOHNSON, PAUL H | EPIGENX PHARMACEUTICALS | TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING | Complete |
2018 | R43 | CA236101 | PAR-18-303 | LEE, LY JAMES | NANOMATERIAL INNOVATION, LTD | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis | Complete |
1999 | R43 | CA083388 | PAR-98-066 | CRONIN, MAUREEN T. | PROTOGENE LABORATORIES, INC. | DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD | Complete |
2017 | R43 | CA214386 | PAR-13-327 | PEYTAVI, REGIS | BLUENOVO BIOSYSTEMS, INC. | Detection of Methylation and Translocation Events by Novel Sequencing Technology | Complete |
2000 | R43 | CA088381 | PAR-99-101 | RENARD, ANDRE | INTERGEN COMPANY | PYRENE-CONTAINING PROBES FOR MUTATION DETECTION | Complete |
2002 | R43 | CA097507 | PAR-01-105 | MC GARRITY, GERARD J. | INTRONN, INC. | PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER | Complete |
2018 | R43 | CA236142 | PAR-18-303 | SCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC. | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes | Complete |
1999 | R43 | CA083390 | PAR-98-066 | WIKTOR, PETER J. | ENGINEERING ARTS | PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS | Complete |
2000 | R43 | CA088396 | PAR-99-101 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS | Complete |
2000 | R43 | CA088696 | PAR-99-101 | CHO, RAYMOND JAIHYUN | INGENUITY SYSTEMS, INC. | FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS | Complete |
2019 | R43 | CA236103 | PAR-18-303 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC. | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | Complete |
1999 | R43 | CA083396 | PAR-98-066 | GITE, SADANAND | AMBERGEN, INC | NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION | Complete |